Budget 2018-19

  So far, only those above 45 who had certain co-morbidities were allowed to take the vaccine after producing a letter from a registered doctor The government has decided to open up its Covid-19 vaccination drive for all above 45 years of age from April 1, and requested that all eligible people should “immediately register and get vaccinated”. The rest of the population could be considered for vaccination coverage once the current stage is over.The government has decided to open up its Covid-19 vaccination drive for all above 45 years of age from April 1, and requested that all eligible people should “immediately register and get vaccinated”. The rest of the population could be considered for vaccination coverage once the current stage is over. The government has decided to open up its  Covid-19 vaccination  drive for all above 45 years of age from April 1, and requested that all eligible people should “immediately register and get vaccinated”. The rest of the population ...

  Also, continued collaboration across institutions was necessary to come out of the current situation as well as ward off catastrophic situations, he said Council of Scientific and Industrial Research (CSIR) Director General Shekhar C Mande on Sunday warned that the COVID-19 crisis was far from being over and allowing a “third wave” by lowering our guard is fraught with grave consequences.Also, continued collaboration across institutions was necessary to come out of the current situation as well as ward off catastrophic situations arising out of climate change and over dependence on fossil fuels which had the potential to wipe out the entire humanity, he said Mande was speaking on “India’s response to Covid-19 from S & T perspective” at a virtual “National Science Day Lectures,” organised by Rajiv Gandhi Centre for Biotechnology here. The expert clarified that India is nowhere near achieving herd immunity and as such people should continue to wear masks and maintain social dis...

  The World Health Organization says it has cleared the Pfizer-BioNTech coronavirus vaccine for emergency use The World Health Organization says it has cleared the Pfizer-BioNTech coronavirus vaccine for emergency use, meaning poorer countries may soon get access to the shot already available in Europe and North America. Every country that has a drug regulatory agency will have to issue its own approval for any COVID-19 vaccine, but countries with weak systems usually rely on WHO to vet the shots. The global body said late Thursday that the decision to issue its first emergency use validation for a COVID-19 vaccine “opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine.” The UN health agency said its review found the  Pfizer-BioNTech vaccine , which has already received clearance in the United States, Britain, the European Union and a dozen other countries, “met the must-have criteria for safety and efficacy set o...

  The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer. Ursula von der Leyen, the president of the EU’s executive arm, said the commission will authorize the deal on Wednesday after working tirelessly to secure doses of potential vaccines in recent months. This is the most promising vaccine so far, von der Leyen said. Once this vaccine becomes available, our plan is to deploy it quickly, everywhere in Europe. Pfizer said Monday that early results from the vaccine suggests the shots may be a surprisingly robust 90% effective at preventing COVID-19. The European Commission had already secured three other deals with pharmaceutical companies allowing its 27 member states to buy nearly one billion doses of a potential  coronavirus vaccine. And...

  Indonesia will at the first phase provide the Covid-19 vaccine to 9.1 million people between November and December 2020 Indonesia will at the first phase provide the COVID-19 vaccine to 9.1 million people between November and December 2020, the Health Ministry’s Disease Control and Prevention Director General Achmad Yurianto said. The first phase of vaccination will be carried out on the groups of people with highest risk of COVID-19 infections, namely medical and public service workers including airport employees, soldiers and police personnel, Xinhua news agency reported on Monday. Yurianto said that the vaccine would only be given to people aged between 18 years old and 59 years old, because clinical trials of vaccine candidates in the world have yet to target categories outside that age range. The vaccination will be carried out after the Indonesian Drug and Food Supervisory Agency (BPOM) issues an emergency use authorization and the Indonesian Ulema Council (MUI) provides ha...